Genomic Characterization of Clinical <i>Acinetobacter baumannii</i> Isolates Obtained from COVID-19 Patients in Russia
The coronavirus disease 2019 (COVID-19) pandemic has already affected all realms of public healthcare and, in particular, has led to increasing use of various antibiotics to treat possible bacterial coinfections even in cases for which such infections were not confirmed clinically. This could lead t...
Main Authors: | Andrey Shelenkov, Yulia Mikhaylova, Lyudmila Petrova, Irina Gaidukova, Mikhail Zamyatin, Vasiliy Akimkin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/11/3/346 |
Similar Items
-
Diversity of International High-Risk Clones of <i>Acinetobacter baumannii</i> Revealed in a Russian Multidisciplinary Medical Center during 2017–2019
by: Andrey Shelenkov, et al.
Published: (2021-08-01) -
Genomic Epidemiology Dataset for the Important Nosocomial Pathogenic Bacterium <i>Acinetobacter baumannii</i>
by: Andrey Shelenkov, et al.
Published: (2024-01-01) -
Genomic and Phenotypic Analysis of Multidrug-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates Carrying Different Types of CRISPR/Cas Systems
by: Marina Tyumentseva, et al.
Published: (2021-02-01) -
International Clones of High Risk of Acinetobacter Baumannii—Definitions, History, Properties and Perspectives
by: Andrey Shelenkov, et al.
Published: (2023-08-01) -
Genomic Investigation of Two <i>Acinetobacter baumannii</i> Outbreaks in a Veterinary Intensive Care Unit in The Netherlands
by: Soe Yu Naing, et al.
Published: (2022-01-01)